--Denifanstat (ASC40) met all primary, key secondary and secondary efficacy endpoints (ITT analysis) and significantly improved moderate-to-severe acne compared with placebo. --Denifanstat (ASC40) ...

Denifanstat (ASC40), a once-daily oral fatty acid synthase (FASN) inhibitor, demonstrated statistically significant and clinically meaningful improvement compared to placebo in all primary, key ...

No matter your age, having persistent acne can feel disheartening. You may have tried countless treatment options, ranging from dietary changes to medical treatment, but nothing has worked. Some ...

No teen wants to have acne, but those who do may find comfort in research that suggests the dreaded rite of passage is linked to some very good outcomes in life. The recent study, titled “Do Pimples ...